Skip to main content
. 2011 Apr 8;22(9):1143–1153. doi: 10.1089/hum.2010.245

Table 1.

Constructs Packaged in AAV

Construct Enhancer Promoter Intron Poly(A)
CMV-GFP CMV earlya CMV earlyb Chimeric hβ-Globinc/mIgGd SV40 earlye
CBA-GFP CMV earlya chβ-Actinf Truncated SV40 late 16Sg BGHh
CBh-GFP CMV earlya chβ-Actinf Chimeric chβ-Actini/MVMj BGHh
MeP-GFP NA mMeCP2k NA Syntheticl

NA, not applicable; for other abbreviations see text.

a

GenBank accession no. NC_006273.2, nt 175625–175294.

b

GenBank accession no. NC_006273.2, nt 175043–175294.

c

GenBank accession no. AC_000054.1, nt 5366740–5366826.

d

GenBank accession no. L26879.1, nt 678–705.

e

GenBank accession no. NC_001669.1, nt 2548–2774.

f

GenBank accession no. X00182.1, nt 280–540.

g

GenBank accession no. NC_001669.1, nt 502–561, 1410–1497.

h

Bovine growth hormone, GenBank accession no. EF592533.1, nt 1827–2034.

i

GenBank accession no. X00182.1, nt 544–676.

j

GenBank accession no. NC_001510.1, nt 2312–2403 (VP intron).

k

See Adachi et al. (2005), nt−170 to+53 from mapped transcription start.

l

Synthetic, based on Levitt et al. (1989).

HHS Vulnerability Disclosure